Bacteriophage types and antibiotic susceptibility of Staphylococcus aureus. Boston City Hospital, 1967.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001414:Bacitracin / Q000494:pharmacology; D001434:Bacteriophage Typing; D001900:Boston; D002509:Cephaloridine / Q000494:pharmacology; D002701:Chloramphenicol / Q000494:pharmacology; D003428:Cross Infection; D004352:Drug Resistance, Microbial; D004917:Erythromycin / Q000494:pharmacology; D006801:Humans; D007612:Kanamycin / Q000494:pharmacology; D008034:Lincomycin / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D009675:Novobiocin / Q000494:pharmacology; D010403:Penicillin Resistance; D013203:Staphylococcal Infections; D013210:Staphylococcus / Q000187:drug effects*; D013752:Tetracycline / Q000494:pharmacology; D014640:Vancomycin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D001414:Bacitracin; D009675:Novobiocin; D007612:Kanamycin; D004917:Erythromycin; D002701:Chloramphenicol; D014640:Vancomycin; D008034:Lincomycin; D013752:Tetracycline; D002509:Cephaloridine